BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1946523)

  • 21. New methods for studying the proliferation and differentiation of epidermal keratinocytes from adult mice.
    Morris RJ; Fischer SM; Slaga TJ
    Prog Clin Biol Res; 1991; 369():303-22. PubMed ID: 1946527
    [No Abstract]   [Full Text] [Related]  

  • 22. Re: E. Farber, Cell proliferation as a major risk factor for cancer: a concept of doubtful validity. Cancer Res., 55: 3759-3762, 1995.
    Ames BN; Gold LS
    Cancer Res; 1996 Sep; 56(18):4267-9; author reply 4272-4. PubMed ID: 8797604
    [No Abstract]   [Full Text] [Related]  

  • 23. Chemically induced cell proliferation. Implications for risk assessment. Proceedings of the Chemically Induced Cell Proliferation Conference. Austin, Texas, November 29-December 2, 1989.
    Prog Clin Biol Res; 1991; 369():1-532. PubMed ID: 1682944
    [No Abstract]   [Full Text] [Related]  

  • 24. DNA synthesis and transformation induced in density-inhibited cultures of hamster embryo cells by the carcinogen benzo(alpha)pyrene.
    Mironescu S; Love R
    Cancer Res; 1974 Oct; 34(10):2562-70. PubMed ID: 4472076
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition of cyclooxygenase-2 with NS-398 and the prevention of radiation-induced transformation, micronuclei formation and clonogenic cell death in C3H 10T1/2 cells.
    Bisht KS; Bradbury CM; Zoberi I; Curry HA; Kaushal A; Roti Roti JL; Gius D
    Int J Radiat Biol; 2003 Nov; 79(11):879-88. PubMed ID: 14698956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A carcinogens--methods for detecting environmental muta/carcinogens].
    Morimoto K; Koizumi A
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):789-97. PubMed ID: 3885860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of cell transformation systems for carcinogenicity testing and mechanistic studies of carcinogenesis.
    Barrett JC; Hesterberg TW; Thomassen DG
    Pharmacol Rev; 1984 Jun; 36(2 Suppl):53S-70S. PubMed ID: 6473503
    [No Abstract]   [Full Text] [Related]  

  • 28. [Mutagenic properties of environmental carcinogens].
    Pashin IuV; Bakhitova LM
    Vopr Onkol; 1980; 26(8):94-7. PubMed ID: 6998117
    [No Abstract]   [Full Text] [Related]  

  • 29. Role of chemically induced cell proliferation in carcinogenesis and its use in health risk assessment.
    Croy RG
    Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):289-302. PubMed ID: 8013422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spontaneous and induced transformation of human leukocytes in vitro.
    Chang RS; Blankenship W; Golden HD; Mishra L; Chang YY
    Birth Defects Orig Artic Ser; 1973 Jan; 9(1):40-54. PubMed ID: 4347335
    [No Abstract]   [Full Text] [Related]  

  • 31. Carcinogenicity and mutagenicity of some metals and their compounds.
    Sunderman FW
    IARC Sci Publ; 1986; (71):17-43. PubMed ID: 3770853
    [No Abstract]   [Full Text] [Related]  

  • 32. [In Search of the mechanism of neoplastic cell transformation--the current confused state].
    Watanabe M
    Radioisotopes; 1983 May; 32(5):249-59. PubMed ID: 6414056
    [No Abstract]   [Full Text] [Related]  

  • 33. Estimation of the potencies of chemicals that produce genetic damage.
    Peterson AR; Peterson H
    Carcinog Compr Surv; 1985; 10():495-509. PubMed ID: 3904996
    [No Abstract]   [Full Text] [Related]  

  • 34. Carcinogen-induced impairment of enzymes for replicative fidelity of DNA and the initiation of tumours.
    Bignold LP
    Carcinogenesis; 2004 Mar; 25(3):299-307. PubMed ID: 14604890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumorigenesis by exogenous carcinogens: role of target-cell proliferation and state of differentiation (development).
    Rajewsky MF
    IARC Sci Publ; 1985; (58):215-24. PubMed ID: 3830876
    [No Abstract]   [Full Text] [Related]  

  • 36. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutagenicity and carcinogenicity of biological reactive intermediate's derived from a "non-genotoxic" carcinogen.
    Lau SS; Yoon HS; Patel SK; Everitt JI; Walker CL; Monks TJ
    Adv Exp Med Biol; 2001; 500():83-92. PubMed ID: 11765020
    [No Abstract]   [Full Text] [Related]  

  • 38. Low doses and thresholds in genotoxicity: from theories to experiments.
    Zito R
    J Exp Clin Cancer Res; 2001 Sep; 20(3):315-25. PubMed ID: 11718209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Carcinogenesis and cytogenetics. Application to gastrointestinal cancer].
    Couturier D; Couturier-Turpin MH; Grandjouan S
    Gastroenterol Clin Biol; 1983 Nov; 7(11):877-93. PubMed ID: 6360784
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of DNA lesions and DNA repair in mutagenesis by carcinogens in diploid human fibroblasts.
    Maher VM; McCormick JJ
    Prog Clin Biol Res; 1986; 209A():245-53. PubMed ID: 3749044
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.